Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (61-70 of 261) with videos related to

Pageof 27
Sort By:
Alimentary Pharmacology & Therapeutics|June 11, 2024
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?Stuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Plos Medicine|May 1, 2020
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studiesHelen Jarvis, Dawn Craig, Robert Barker, et al.
Journal of Hepatology|December 6, 2014
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical managementStuart McPherson, Tim Hardy, Elsbeth Henderson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Variance Between Clinical Guidance and Real-World Management of Metabolic Dysfunction-associated Steatotic Liver Disease in the United StatesMary E Rinella, Mark L Hartman, Shraddha Shinde, et al.
BMC Gastroenterology|May 10, 2018
Thrombin and factor Xa link the coagulation system with liver fibrosisAmeet Dhar, Fouzia Sadiq, Quentin M Anstee, et al.
Gastroenterology|February 3, 2015
TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?Bratati Kahali, Yang-Lin Liu, Ann K Daly, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 10, 2022
The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysisLaura Haigh, Colette Kirk, Khalil El Gendy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2020
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic reviewJenny Lee, Yasaman Vali, Jerome Boursier, et al.
JHEP Reports : Innovation in Hepatology|June 28, 2021
Embedding assessment of liver fibrosis into routine diabetic review in primary careDina Mansour, Allison Grapes, Marc Herscovitz, et al.
Nature Reviews. Gastroenterology & Hepatology|September 21, 2017
Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionZobair Younossi, Quentin M Anstee, Milena Marietti, et al.
Pageof 27

Showing results (61-70 of 261) with videos related to

Sort By:
Pageof 27
Alimentary Pharmacology & Therapeutics|June 11, 2024
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?Stuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Plos Medicine|May 1, 2020
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studiesHelen Jarvis, Dawn Craig, Robert Barker, et al.
Journal of Hepatology|December 6, 2014
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical managementStuart McPherson, Tim Hardy, Elsbeth Henderson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Variance Between Clinical Guidance and Real-World Management of Metabolic Dysfunction-associated Steatotic Liver Disease in the United StatesMary E Rinella, Mark L Hartman, Shraddha Shinde, et al.
BMC Gastroenterology|May 10, 2018
Thrombin and factor Xa link the coagulation system with liver fibrosisAmeet Dhar, Fouzia Sadiq, Quentin M Anstee, et al.
Gastroenterology|February 3, 2015
TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?Bratati Kahali, Yang-Lin Liu, Ann K Daly, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 10, 2022
The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysisLaura Haigh, Colette Kirk, Khalil El Gendy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2020
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic reviewJenny Lee, Yasaman Vali, Jerome Boursier, et al.
JHEP Reports : Innovation in Hepatology|June 28, 2021
Embedding assessment of liver fibrosis into routine diabetic review in primary careDina Mansour, Allison Grapes, Marc Herscovitz, et al.
Nature Reviews. Gastroenterology & Hepatology|September 21, 2017
Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionZobair Younossi, Quentin M Anstee, Milena Marietti, et al.
Pageof 27